Stroke: causes and clinical features
Stephen Jx Murphy, David J Werring, Stephen Jx Murphy, David J Werring
Abstract
Stroke is a clinically defined syndrome of acute, focal neurological deficit attributed to vascular injury (infarction, haemorrhage) of the central nervous system. Stroke is the second leading cause of death and disability worldwide. Stroke is not a single disease but can be caused by a wide range of risk factors, disease processes and mechanisms. Hypertension is the most important modifiable risk factor for stroke, although its contribution differs for different subtypes. Most (85%) strokes are ischaemic, predominantly caused by small vessel arteriolosclerosis, cardioembolism and large artery athero-thromboembolism. Ischaemic strokes in younger patients can result from a different spectrum of causes such as extracranial dissection. Approximately 15% of strokes worldwide are the result of intracerebral haemorrhage, which can be deep (basal ganglia, brainstem), cerebellar or lobar. Deep haemorrhages usually result from deep perforator (hypertensive) arteriopathy (arteriolosclerosis), while lobar haemorrhages are mainly caused by cerebral amyloid angiopathy or arteriolosclerosis. A minority (about 20%) of intracerebral haemorrhages are caused by macrovascular lesions (vascular malformations, aneurysms, cavernomas), venous sinus thrombosis or rarer causes; these are particularly important in young patients (<50 years). Knowledge of vascular and cerebral anatomy is important in localizing strokes and understanding their mechanisms. This guides rational acute management, investigation, and secondary prevention.
Keywords: Cerebrovascular disease; MRCP; intracerebral haemorrhage; ischaemic stroke; stroke pathogenesis; stroke risk factors; transient ischaemic attack.
© 2020 Published by Elsevier Ltd.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7409792/bin/gr1_lrg.jpg)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7409792/bin/gr2_lrg.jpg)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/7409792/bin/gr3_lrg.jpg)
References
- Adams H.P., Jr., Bendixen B.H., Kappelle L.J., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke. 1993;24:35–41.
- O'Donnell M.J., Chin S.L., Rangarajan S., et al. Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (Interstroke): a case-control study. Lancet. 2016;388:761–775.
- Malik R., Chauhan G., Traylor M., et al. Multiancestry genome-wide association study of 520,000 subjects identifies 32 loci associated with stroke and stroke subtypes. Nat Genet. 2018;50:524–537.
- Banerjee G., Carare R., Cordonnier C., et al. The increasing impact of cerebral amyloid angiopathy: essential new insights for clinical practice. J Neurol Neurosurg Psychiatry. 2017;88:982–994.
- Banerjee G., Stone S.P., Werring D.J. Posterior circulation ischaemic stroke. Br Med J. 2018;361:k1185.
Source: PubMed